ACPU
MJN

Arrowgrass Capital Partners (US)’s Mead Johnson Nutrition Company MJN Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,000
Closed -$53.4M – 661
2017
Q1 		$53.4M Buy
+6,000
New +$493K 0.55% 36

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s MJN Position: Q2 2017 in Review

Arrowgrass Capital Partners (US) sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 458 shares — an estimated $41K sold.

Arrowgrass Capital Partners (US) first reported a position in MJN in Q3 2013 and held it in 5 quarters. The position peaked at $7.43M in Q3 2013. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Arrowgrass Capital Partners (US) reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 458 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $41K.
  • Arrowgrass Capital Partners (US) first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 5 quarters.
  • Arrowgrass Capital Partners (US)'s Mead Johnson Nutrition Company position peaked at $7.43M in Q3 2013.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2017, filed 14 Aug 2017.